Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 30, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 19,640	$ 98,075
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	79,164	78,619
Gain on disposal of property, plant, equipment and other assets	(4,250)	(462)
Loss on disposal of subsidiaries	0
Gain on insurance proceeds from insurance settlements	(845)	(503)
Deferred taxes	(2,901)	(2,649)
Increase in long-term pension liability	646	159
Stock-based compensation expense	10,327	8,992
Write-off deferred loan costs	27	0
Deferred loan cost amortization	1,574	2,939
Equity in net income of unconsolidated subsidiaries	(23,773)	(97,154)
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	11,692	(14,590)
Income taxes refundable/payable	7,270	(1,384)
Inventories and prepaid expenses	(5,063)	(10,182)
Accounts payable and accrued expenses	(43,016)	(38,422)
Other	(1,891)	3,486
Net cash provided by operating activities	48,601	26,924
Cash flows from investing activities:
Capital expenditures	(84,269)	(56,587)
Acquisitions, net of cash acquired	(1,431)	0
Investment in unconsolidated subsidiary	0	(3,500)
Proceeds from sale of investment in subsidiary	0	2,805
Gross proceeds from disposal of property, plant and equipment and other assets	7,868	1,479
Proceeds from insurance settlement	845	503
Payments related to routes and other intangibles	(2,778)	(15)
Net cash used by investing activities	(79,765)	(55,315)
Cash flows from financing activities:
Proceeds from long-term debt	2,138	3,876
Payments on long-term debt	(10,974)	(9,622)
Borrowings from revolving credit facility	156,829	135,184
Payments on revolving credit facility	(138,147)	(80,019)
Net cash overdraft financing	14,525	(331)
Deferred loan costs	0	(1,094)
Issuance of common stock	12	182
Minimum withholding taxes paid on stock awards	(3,190)	(2,018)
Net cash provided by financing activities	21,193	46,158
Effect of exchange rate changes on cash	(1,575)	(1,672)
Net increase/(decrease) in cash, cash equivalents and restricted cash	(11,546)	16,095
Cash, cash equivalents and restricted cash at beginning of period	107,369	106,916
Cash, cash equivalents and restricted cash at end of period	95,823	123,011
Supplemental disclosure of cash flow information:
Accrued capital expenditures	(8,623)	(1,934)
Cash paid during the period for:
Interest, net of capitalized interest	21,602	19,142
Income taxes, net of refunds	2,894	7,120
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	4,794	0
Debt issued for assets	$ 0	$ 17